WILLOW BIOSCIENCES TO HOST INVESTOR PRESENTATION WEBCAST
Willow Biosciences Inc. (OTCQB: CANSF) announced a live webcast investor presentation on February 3rd, 2022, at 2:00 PM EST. President and CEO Trevor Peters will discuss key business areas and engage with investors through a Q&A session. Interested participants must pre-register for the event through the provided link. An archived version of the presentation will be accessible on the company's website afterward. Willow specializes in sustainable cannabinoid production using its FutureGrown™ platform, aiming to benefit various markets.
- None.
- None.
VANCOUVER, BC, Jan. 31, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company that manufactures pure, consistent and sustainable cannabinoids via yeast biosynthesis, today announced that it will host a webcast investor presentation on Thursday, February 3rd at 2:00 PM EST.
During the webcast, Willow's President and Chief Executive Officer Trevor Peters will provide a presentation through a PowerPoint discussion that will cover key areas of Willow's business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal.
To listen to the webcast or to ask questions during the live event, please pre-register at the following link:
https://event.webcasts.com/starthere.jsp?ei=1522256&tp_key=5868b5db75
An archived version of the webcast and presentation will be available on the Company's website, www.willowbio.com/#investors.
About Willow Biosciences Inc.
Willow is a leading biotechnology company that develops and produces high-purity, plant derived ingredients for the consumer care, food and beverage, and pharmaceutical markets. Willow's FutureGrown™ biotechnology platform allows scale production of pure, consistent, and sustainable product to benefit both B2B and B2C customers. Willow's R&D team has a proven track record of developing and commercializing bio-based manufacturing processes and products for both the consumer and pharmaceutical industries.
Forward-Looking Statements
This news release may include forward-looking statements including opinions, assumptions, estimates and the Company's assessment of future plans and operations, and, more particularly, statements concerning the business plan of the Company, generally, including cannabinoid research and production. When used in this news release, the words "will," "anticipate," "believe," "estimate," "expect," "intent," "may," "project," "should," and similar expressions are intended to be among the statements that identify forward-looking statements. The forward-looking statements are founded on the basis of expectations and assumptions made by the Company. Any number of important factors could cause actual results to differ materially from those in the forward-looking statements. Please refer to the Company's most recent annual information form and management's discussion and analysis for l risk factors relating to Willow, which can be accessed either on Willow's website at www.willowbio.com or under the Company's profile on www.sedar.com.
The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/willow-biosciences-to-host-investor-presentation-webcast-301471239.html
SOURCE Willow Biosciences Inc.
FAQ
When is Willow Biosciences' investor presentation webcast scheduled?
Who will present at the Willow Biosciences webcast?
How can I participate in the Willow Biosciences investor presentation?
Where can I find the archived version of the Willow Biosciences webcast?
What is the focus of Willow Biosciences' business?
